Effects of propofol on myocardial ischemia‑reperfusion injury in rats with type‑2 diabetes mellitus

Wang,Ying; Qi,Xiuru; Wang,Chunliang; Zhao,Danning; Wang,Hongjie; Zhang,Jianxin

doi:10.3892/br.2016.805

Effects of propofol on myocardial ischemia‑reperfusion injury in rats with type‑2 diabetes mellitus

Authors:
- Ying Wang
- Xiuru Qi
- Chunliang Wang
- Danning Zhao
- Hongjie Wang
- Jianxin Zhang
View Affiliations

Affiliations: Department of Anesthesiology, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China, Department of Pharmacology, Hebei Academy of Medical Sciences, Shijiazhuang, Hebei 050021, P.R. China
Published online on: November 9, 2016 https://doi.org/10.3892/br.2016.805
Pages: 69-74

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The current study aimed to examine the effects of propofol on myocardial ischemia-reperfusion injury (MIRI) in rats with type‑2 diabetes mellitus (T2DM) and to assess the role of inflammatory mediators. Fifty healthy male adult Sprague‑Dawley rats were randomly divided into the sham, ischemia‑reperfusion (IR), IR plus low, middle and high‑dose (6, 12 and 24 mg/kg/h, intravenous) propofol groups. The rats of all the groups were fed a high‑sugar and high‑fat diet for 8 weeks and streptozotocin (30 mg/kg, intraperitoneally) was used to establish the T2DM model. Apart from the sham group rats, MIRI was induced by ligating the left anterior descending coronary artery for 30 min, followed by reperfusion for 2 h. Heart rate (HR), left ventricular systolic pressure (LVSP), and the rate of left ventricular pressure increase in early systole (± dp/dtmax) were recorded. Levels of cardiac troponin T (cTnT), nitric oxide (NO), endothelin‑1 (ET‑1), interleukin (IL)‑1β, IL‑6, and tumor necrosis factor (TNF)‑α were also measured. Myocardial lesions were observed under light microscopy and scanning electron microscopy. Compared with levels prior to arterial occlusion, HR, LVSP, and ± dp/dtmax were significantly reduced (P<0.05) following occlusion for 30 min and reperfusion for 2 h. The administration of propofol ameliorated the cardiac function of rats as reflected by the increase in HR, LVSP and ± dp/dtmax. In addition, the administration of propofol increased the serum NO concentration, and reduced ET‑1 and cTnT levels, as well as levels of inflammatory mediators including IL‑1β, IL‑6 and TNF‑α. Thus, propofol exerts protective effects against MIRI in T2DM rats by increasing NO and reducing ET‑1 and the inflammatory mediators.

View Figures

View References

1	Shaw JE, Sicree RA and Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar : PubMed/NCBI
2	de Mattos Matheus AS, Righeti Monteiro Tannus L, Roberta Arnoldi Cobas R, Palma CC Sousa, Negrato CA and de Brito Gomes M: Impact of diabetes on cardiovascular disease: An update (Review). Int J Hypertens. 2013:6537892013.PubMed/NCBI
3	Sun L and Kanwar YS: Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy. Kidney Int. 88:662–665. 2015. View Article : Google Scholar : PubMed/NCBI
4	Hashmi S and Al-Salam S: Acute myocardial infarction and myocardial ischemia-reperfusion injury: A comparison. Int J Clin Exp Pathol. 8:8786–8796. 2015.PubMed/NCBI
5	Halladin NL: Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries. Dan Med J. 62:B50542015.PubMed/NCBI
6	Marfella R, Di Filippo C, Portoghese M, Siniscalchi M, Martis S, Ferraraccio F, Guastafierro S, Nicoletti G, Barbieri M, Coppola A, et al: The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: The role of glycemic control. Cardiovasc Pathol. 18:332–345. 2009. View Article : Google Scholar : PubMed/NCBI
7	Yao X, Li Y, Tao M, Wang S, Zhang L, Lin J, Xia Z and Liu HM: Effects of glucose concentration on propofol cardioprotection against myocardial ischemia reperfusion injury in isolated rat hearts. J Diabetes Res. 2015:5920282015. View Article : Google Scholar : PubMed/NCBI
8	Liu F, Chen MR, Liu J, Zou Y, Wang TY, Zuo YX and Wang TH: Propofol administration improves neurological function associated with inhibition of pro-inflammatory cytokines in adult rats after traumatic brain injury. Neuropeptides. 58:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
9	Markovic-Bozic J, Karpe B, Potocnik I, Jerin A, Vranic A and Novak-Jankovic V: Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC Anesthesiol. 16:182016. View Article : Google Scholar : PubMed/NCBI
10	Samir A, Gandreti N, Madhere M, Khan A, Brown M and Loomba V: Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot study. Ann Card Anaesth. 18:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
11	Jennings MA, Brock LG and Florey L: A comparison of connective tissue lining aortic grafts with extravascular connective tissue. Proc R Soc Lond B Biol Sci. 165:206–223. 1966. View Article : Google Scholar : PubMed/NCBI
12	Cha SA, Yun JS, Lim TS, Hwang S, Yim EJ, Song KH, Yoo KD, Park YM, Ahn YB and Ko SH: Severe hypoglycemia and cardiovascular or all-cause mortality in patients with type 2 diabetes. Diabetes Metab J. 40:202–210. 2016. View Article : Google Scholar : PubMed/NCBI
13	Lee E, Oh HJ, Park JT, Han SH, Ryu DR, Kang SW and Yoo TH: The incidence of cardiovascular events is comparable between normoalbuminuric and albuminuric diabetic patients with chronic kidney disease. Medicine (Baltimore). 95:e31752016. View Article : Google Scholar : PubMed/NCBI
14	Shao H, Li J, Zhou Y, Ge Z, Fan J, Shao Z and Zeng Y: Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: Role of cardiolipin. Br J Pharmacol. 153:1641–1649. 2008. View Article : Google Scholar : PubMed/NCBI
15	Noh HS, Shin IW, Ha JH, Hah Y-S, Baek SM and Kim DR: Propofol protects the autophagic cell death induced by the ischemia/reperfusion injury in rats. Mol Cells. 30:455–460. 2010. View Article : Google Scholar : PubMed/NCBI
16	Furchgott RF and Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373–376. 1980. View Article : Google Scholar : PubMed/NCBI
17	Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:411–415. 1988. View Article : Google Scholar : PubMed/NCBI
18	Moncada S, Palmer RM and Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:109–142. 1991.PubMed/NCBI
19	Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J and Lodato RF: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun. 172:1132–1138. 1990. View Article : Google Scholar : PubMed/NCBI
20	Wildhirt SM, Dudek RR, Suzuki H, Pinto V, Narayan KS and Bing RJ: Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res. 29:526–531. 1995. View Article : Google Scholar : PubMed/NCBI
21	Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kamada T, Kuzuya T and Tada M: Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther. 274:413–418. 1995.PubMed/NCBI
22	Yao SK, Akhtar S, Scott-Burden T, Ober JC, Golino P, Buja LM, Casscells W and Willerson JT: Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation. 92:1005–1010. 1995. View Article : Google Scholar : PubMed/NCBI
23	Zweier JL, Wang P and Kuppusamy P: Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem. 270:304–307. 1995. View Article : Google Scholar : PubMed/NCBI
24	Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, Tada M, Hori M and Kamada T: Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation. 93:356–364. 1996. View Article : Google Scholar : PubMed/NCBI
25	Mayyas F, Al-Jarrah M, Ibrahim K, Mfady D and Van Wagoner DR: The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization. Cardiovasc Pathol. 24:19–25. 2015. View Article : Google Scholar : PubMed/NCBI
26	Lewicki L, Siebert J, Marek-Trzonkowska N, Masiewicz E, Kolinski T, Reiwer-Gostomska M, Targonski R and Trzonkowski P: Elevated serum tryptase and endothelin in patients with ST segment elevation myocardial infarction: Preliminary report. Mediators Inflamm. 2015:3951732015. View Article : Google Scholar : PubMed/NCBI
27	Kolettis TM, Barton M, Langleben D and Matsumura Y: Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev. 21:249–256. 2013. View Article : Google Scholar : PubMed/NCBI
28	Chen J, Chen MH, Guo YL, Zhu CG, Xu RX, Dong Q and Li JJ: Plasma big endothelin-1 level and the severity of new-onset stable coronary artery disease. J Atheroscler Thromb. 22:126–135. 2015. View Article : Google Scholar : PubMed/NCBI
29	Carswell EA, Old LJ, Kassel RL, Green S, Fiore N and Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 72:3666–3670. 1975. View Article : Google Scholar : PubMed/NCBI
30	Tang X, Marciano DL, Leeman SE and Amar S: LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA. 102:5132–5137. 2005. View Article : Google Scholar : PubMed/NCBI
31	Kleine TO, Zwerenz P, Zöfel P and Shiratori K: New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF). Brain Res Bull. 61:287–297. 2003. View Article : Google Scholar : PubMed/NCBI
32	Li X, Huang Q, Ong CN, Yang XF and Shen HM: Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett. 293:109–116. 2010. View Article : Google Scholar : PubMed/NCBI
33	Singh U, Kumar A, Sinha R, Manral S, Arora S, Ram S, Mishra RK, Gupta P, Bansal SK, Prasad AK, et al: Calreticulin transacetylase catalyzed modification of the TNF-alpha mediated pathway in the human peripheral blood mononuclear cells by polyphenolic acetates. Chem Biol Interact. 185:263–70. 2010. View Article : Google Scholar : PubMed/NCBI
34	Suzuki Y, Deitch EA, Mishima S, Lu Q and Xu D: Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med. 28:3692–3696. 2000. View Article : Google Scholar : PubMed/NCBI
35	Oleszycka E, Moran HB, Tynan GA, Hearnden CH, Coutts G, Campbell M, Allan SM, Scott CJ and Lavelle EC: IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination. FEBS J. 283:9–24. 2016. View Article : Google Scholar : PubMed/NCBI
36	Ma J, Qiao Z and Xu B: Effects of ischemic preconditioning on myocardium Caspase-3, SOCS-1, SOCS-3, TNF-α and IL-6 mRNA expression levels in myocardium IR rats. Mol Biol Rep. 40:5741–5748. 2013. View Article : Google Scholar : PubMed/NCBI
37	Ishihara Y, Sekine M, Nakazawa M and Shimamoto N: Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats. Eur J Pharmacol. 611:64–71. 2009. View Article : Google Scholar : PubMed/NCBI
38	Hadi NR, Al-Amran F, Yousif M and Zamil ST: Antiapoptotic effect of simvastatin ameliorates myocardial ischemia/reperfusion injury. ISRN Pharmacol. 2013:8150942013. View Article : Google Scholar : PubMed/NCBI